增加输注速率时静脉注射α - 1蛋白酶抑制剂的安全性和耐受性:一项新的、随机、安慰剂掩盖、输注速率控制的健康成人交叉研究

IF 1.4 Q4 MEDICINE, RESEARCH & EXPERIMENTAL

Open Access Journal of Clinical Trials Pub Date : 2014-06-23 DOI:10.2147/OAJCT.S62754

L. Ngo, A. Haeberle, J. Dyck-Jones, D. Gelmont, L. Yel

{"title":"增加输注速率时静脉注射α - 1蛋白酶抑制剂的安全性和耐受性:一项新的、随机、安慰剂掩盖、输注速率控制的健康成人交叉研究","authors":"L. Ngo, A. Haeberle, J. Dyck-Jones, D. Gelmont, L. Yel","doi":"10.2147/OAJCT.S62754","DOIUrl":null,"url":null,"abstract":"License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php Open Access Journal of Clinical Trials 2014:6 55–61 Open Access Journal of Clinical Trials Dovepress","PeriodicalId":19500,"journal":{"name":"Open Access Journal of Clinical Trials","volume":"6 1","pages":"55-61"},"PeriodicalIF":1.4000,"publicationDate":"2014-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/OAJCT.S62754","citationCount":"0","resultStr":"{\"title\":\"Safety and tolerability of an intravenously administered alpha1-proteinase inhibitor at an increased infusion rate: a novel, randomized, placebo-masked, infusion rate-controlled, crossover study in healthy adults\",\"authors\":\"L. Ngo, A. Haeberle, J. Dyck-Jones, D. Gelmont, L. Yel\",\"doi\":\"10.2147/OAJCT.S62754\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php Open Access Journal of Clinical Trials 2014:6 55–61 Open Access Journal of Clinical Trials Dovepress\",\"PeriodicalId\":19500,\"journal\":{\"name\":\"Open Access Journal of Clinical Trials\",\"volume\":\"6 1\",\"pages\":\"55-61\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2014-06-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2147/OAJCT.S62754\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open Access Journal of Clinical Trials\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/OAJCT.S62754\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Access Journal of Clinical Trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/OAJCT.S62754","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 0

摘要

许可证。许可的完整条款可在http://creativecommons.org/licenses/by-nc/3.0/上获得。允许非商业用途的工作，没有任何进一步的许可，从多芬医学出版社有限公司，只要工作适当署名。超出许可范围的许可由多芬医疗新闻有限公司管理。有关如何申请许可的信息可在以下网站找到:http://www.dovepress.com/permissions.php Open Access Journal of Clinical Trials 2014:6 55-61 Open Access Journal of Clinical Trials Dovepress

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Safety and tolerability of an intravenously administered alpha1-proteinase inhibitor at an increased infusion rate: a novel, randomized, placebo-masked, infusion rate-controlled, crossover study in healthy adults

License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php Open Access Journal of Clinical Trials 2014:6 55–61 Open Access Journal of Clinical Trials Dovepress

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Open Access Journal of Clinical Trials MEDICINE, RESEARCH & EXPERIMENTAL-

CiteScore

3.90

自引率

0.00%

发文量

审稿时长

16 weeks